Pharmacogenomics : Impact Factor & More
eISSN: 1744-8042pISSN: 1462-2416
Share this on:
Key Metrics
CiteScore 
3.6
H-Index
97
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.64
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmacogenomics
Pharmacogenomics Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacogenomics
U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.
- 3 Aug 2026
- Pharmacogenomics
Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan.
- 31 Jul 2026
- Pharmacogenomics
Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis.
- 30 Jul 2026
- Pharmacogenomics
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.
- 22 Jul 2026
- Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics
U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.
- 3 Aug 2026
- Pharmacogenomics
Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan.
- 31 Jul 2026
- Pharmacogenomics
Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis.
- 30 Jul 2026
- Pharmacogenomics
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.
- 22 Jul 2026
- Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics
FAQs on Pharmacogenomics
How long has Pharmacogenomics been actively publishing? 
What is the publishing frequency of Pharmacogenomics?
How many articles did Pharmacogenomics publish last year?
What is the eISSN & pISSN for Pharmacogenomics?
What is Citescore for Pharmacogenomics?
What is the H Index for Pharmacogenomics ?
What is SNIP score for Pharmacogenomics?
What is the SJR for Pharmacogenomics?
Who is the publisher of Pharmacogenomics?
